NEWS

WIRES

OTHER

Medical Device Biocompatibility and Sterilization Seminars Announced

Four different courses are being offered:

• Course A: Biocompatibility of Medical Devices, two day certification course;
• Course B: Regulatory Toxicology of Medical Devices, an advanced course;
• Course C: Traditional and Novel Sterilization Methods of Medical Devices; and
• Course D: Integrating Risk Management throughout the Product Lifecycle.

Courses will be offered in San Juan, Puerto Rico; Dallas, Texas; Frankfurt, Germany; Philadelphia, Penn.; and Amsterdam, the Netherlands.

The NAMSA Training Series was created to teach those within the medical device industry how to navigate more easily through the product development process and regulatory submissions. Participants will take a hands-on approach to learning and will be presented with a unique opportunity to collaborate with the leading medical device consultants in the industry. Attendees who participate and complete all activities will receive a certificate of completion.

Early registration discounts are now available. For more information regarding NAMSA Advisory Services' 2011 Course Offering, go to http://www.namsa.com/news/seminars/. To view the calendar of courses, please see: http://www.regonline.com/CalendarNET/EventCalendar.aspx?EventID=911039&view=Month or e-mail events@namsa.com.

About Alquest-NAMSA

NAMSA, a worldwide leader in the safety evaluation of medical devices, provides consulting and testing services to medical device manufacturers worldwide. Alquest, a NAMSA company, is a clinical research organization and regulatory consultancy specialized in medical devices, in vitro diagnostics (IVDs), biologics and combination products.

Educational Planning and Development Coordinator
for NAMSA Advisory Services
Tom Huyck, 763-287-3830
events@namsa.com